Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 141 filings

Top spenders & firms Spend by issue

Clear
Q1
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q1
YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $30,000.00 income
Health Issues
View →
1T
OGR for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $20,000.00 income
Health Issues
View →
Q1
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View →
Q1
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
EMPIRE CONSULTING GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View →
Q1
ARNOLD & PORTER KAYE SCHOLER LLP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $490,000.00 income
Health Issues
View →
Q1
TIBER CREEK HEALTH STRATEGIES, INC. for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q1
THORN RUN PARTNERS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q1
EAST END GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $75,000.00 income
Health Issues
View →
Q1
BOSE PUBLIC AFFAIRS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q1
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q1
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
RR
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia
Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Previous Page 6 of 6

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem